Welcome

Welcome

Friday, March 18, 2016

FDA Announces Final Rule on BSE

The Food and Drug Administration Thursday issued a rule finalizing three previously issued interim rules regarding bovine spongiform encephalopathy (in-sef-o-lop-athy), or BSE. The rules were designed to further reduce the potential risk of BSE, commonly referred to as mad cow disease, in human food. The FDA says the final rule provides definitions for prohibited cattle materials and prohibits their use in human food, dietary supplements, and cosmetics, to address the potential risk of BSE. The FDA says the final rules aim to minimize human exposure to certain cattle material that could potentially contain the BSE agent. FDA officials add that the U.S. has long had measures in place to prevent the introduction and spread of BSE, and that the risk of human exposure to the BSE agent from FDA-regulated human food and cosmetics is negligible. Find the complete final rules online at FDA dot gov (www.fda.gov).